On the other hand, a low level of immunohistochemical expression of GR protein was revealed in 12 samples (57.14%), 15 samples (21.74%), and 15 samples (36.59%) of the G1, G2, and G3 tumours, respectively. This evidence concerns the gene GSR and neoplasm.